Medical Condition News

RSS

OncoSynergy's OS2966 receives FDA orphan drug designation for treatment of glioblastoma

OncoSynergy announced today that the FDA Office of Orphan Products Development has granted orphan drug designation for the investigational drug candidate OS2966, a neutralizing anti-CD29 monoclonal antibody, for the treatment of glioblastoma, the most common and deadliest primary adult brain tumor.

12 Aug 2014

Research: First effective web-based treatment for bipolar disorder

The first effective web-based treatment for Bipolar Disorder based on the latest research evidence has been developed by psychologists.

12 Aug 2014

Researchers create synthetic ion transporter that triggers apoptosis in cancer cells

Researchers from the University of Southampton are part of an international team that has helped to create a molecule that can cause cancer cells to self-destruct by carrying sodium and chloride ions into the cells.

12 Aug 2014

Bee, snake, scorpion venom could form basis of new generation of cancer-fighting drugs

Bee, snake or scorpion venom could form the basis of a new generation of cancer-fighting drugs, scientists will report here today.

12 Aug 2014

$New tool could help reduce number of future potentially fatal hip fractures$

New tool could help reduce number of future potentially fatal hip fractures

A new tool is being developed by experts in Manchester which automatically searches medical images for early signs of osteoporosis in the spine by identifying fractures there and could help reduce the number of future potentially fatal hip fractures.

From The University of Manchester 12 Aug 2014

More intensive types of approaches tend to be more effective in treating severely obese teenagers

Nearly 6% of all children and teens in the U.S. are severely obese, and the prevalence of severe obesity is increasing faster than that of moderate obesity or overweight.

12 Aug 2014

Researchers discover how arginine starvation specifically kills cancer cells

Researchers at UC Davis, City of Hope, Taipai Medical University and National Health Research Institutes in Taiwan have discovered how a drug that deprives the cells of a key amino acid specifically kills cancer cells.

12 Aug 2014

Scientists aim to understand and treat painful bladder condition

Taking advantage of technology that can analyze tissue samples and measure the activity of thousands of genes at once, scientists at Wake Forest Baptist Medical Center are on a mission to better understand and treat interstitial cystitis (IC), a painful and difficult-to-diagnose bladder condition.

12 Aug 2014

First peer-reviewed comprehensive expert guidance on the use of neurostimulation for pain

Reflecting groundbreaking international consensus regarding a group of rapidly evolving medical interventions for chronic pain, the International Neuromodulation Society announced it will soon publish the first peer-reviewed comprehensive expert guidance on the appropriate use of neurostimulation for pain.

12 Aug 2014

Seven physicians receive ASTRO grants to advance radiation oncology research

The American Society for Radiation Oncology has selected seven leading physicians to receive a total of $675,000 in awards and grants to advance radiation oncology research. The ASTRO Junior Faculty Career Research Training Award, the ASTRO Residents/Fellows in Radiation Oncology Research Seed Grant and the ASTRO/Radiation Oncology Institute Comparative Effectiveness Research Award will fund studies in radiation and cancer biology, radiation physics, translational research, outcomes/health services research and comparative effectiveness research within radiation oncology.

12 Aug 2014

Researchers create synthetic molecule that can cause cancer cells to self-destruct

Researchers from The University of Texas at Austin and five other institutions have created a molecule that can cause cancer cells to self-destruct by ferrying sodium and chloride ions into the cancer cells.

12 Aug 2014

Discovery of new mechanism could lead to next generation of drugs to treat schizophrenia

Discovery of a new mechanism of drug action could lead to the next generation of drugs to treat schizophrenia.

12 Aug 2014

Community-based program to focus on cancer care research and delivery

Metro Detroit area residents with cancer, and those throughout Michigan, will have access to federally-funded cancer research studies thanks to a five-year grant recently awarded to the Beaumont Cancer Institute. Beaumont Health System is one of 34 community sites participating in the National Cancer Institute's Community Oncology Research Program, also known as NCORP.

12 Aug 2014

Researchers identify link between built environment and disability-related outcomes

Kessler Foundation researchers have identified an association between the built environment and disability-related outcomes for adults with physical impairments.

12 Aug 2014

UChicago Medicine and Advocate Health Care wins NIH grant to find new ways to prevent type 1 diabetes

The University of Chicago Medicine and Advocate Children's Hospital / Advocate Health Care have received a five-year, $1.8-million grant from the National Institutes of Health to find new ways to delay and prevent type 1 diabetes. The grant will establish the first Type 1 Diabetes TrialNet Clinical Center in Chicago.

12 Aug 2014

Research: New ways to help visually impaired better navigate everyday life

Visual impairment comes in many forms, and it's on the rise in America. A University of Cincinnati experiment aimed at this diverse and growing population could spark development of advanced tools to help all the aging baby boomers, injured veterans, diabetics and white-cane-wielding pedestrians navigate the blurred edges of everyday life.

12 Aug 2014

New mechanism of joint destruction grinds away healthy cartilage, worsens osteoarthritis

A new mechanism of joint destruction caused by a natural material that grinds away healthy cartilage and worsens osteoarthritis has been identified in human hip joints for the first time by University of Liverpool scientists.

12 Aug 2014

NGS issues positive coverage decision for PTNS to manage symptoms of OAB

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that National Government Services has issued a positive coverage decision for Posterior Tibial Nerve Stimulation (PTNS) for the treatment of urinary urgency, urinary frequency and urge incontinence associated with overactive bladder (OAB). Coverage for the proprietary Urgent PC device was effective August 10, 2014.

12 Aug 2014

Schizophrenia-linked genetic variations and the developing brain: an interview with Prof. Guo-li Ming

How much is currently known about what happens in the developing brain that puts people at risk of schizophrenia?

11 Aug 2014

Antimalarial agent chloroquine normalizes abnormal tumor blood vessels

A recent study by investigators at VIB and KU Leuven has demonstrated that chloroquine also normalizes the abnormal blood vessels in tumors. This blood vessel normalization results in an increased barrier function on the one hand -- thereby blocking cancer cell dissemination and metastasis -- and in enhanced tumor perfusion on the other hand, which increases the response of the tumor to chemotherapy.

11 Aug 2014

Medical Condition News

OncoSynergy's OS2966 receives FDA orphan drug designation for treatment of glioblastoma

Research: First effective web-based treatment for bipolar disorder

Researchers create synthetic ion transporter that triggers apoptosis in cancer cells

Bee, snake, scorpion venom could form basis of new generation of cancer-fighting drugs

New tool could help reduce number of future potentially fatal hip fractures

More intensive types of approaches tend to be more effective in treating severely obese teenagers

Researchers discover how arginine starvation specifically kills cancer cells

Scientists aim to understand and treat painful bladder condition

First peer-reviewed comprehensive expert guidance on the use of neurostimulation for pain

Seven physicians receive ASTRO grants to advance radiation oncology research

Researchers create synthetic molecule that can cause cancer cells to self-destruct

Discovery of new mechanism could lead to next generation of drugs to treat schizophrenia

Community-based program to focus on cancer care research and delivery

Researchers identify link between built environment and disability-related outcomes

UChicago Medicine and Advocate Health Care wins NIH grant to find new ways to prevent type 1 diabetes

Research: New ways to help visually impaired better navigate everyday life

New mechanism of joint destruction grinds away healthy cartilage, worsens osteoarthritis

NGS issues positive coverage decision for PTNS to manage symptoms of OAB

Schizophrenia-linked genetic variations and the developing brain: an interview with Prof. Guo-li Ming

Antimalarial agent chloroquine normalizes abnormal tumor blood vessels

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News